Assessing glycemic and weight-lowering potential of oral semaglutide in type 2 diabetes compared to other GLP-1 receptor agonists in Indian context

IF 0.7 4区医学 Q4 ENDOCRINOLOGY & METABOLISM

International Journal of Diabetes in Developing Countries Pub Date : 2024-04-17 DOI:10.1007/s13410-024-01337-1

Awadhesh Kumar Singh, Rajeev Chawla

引用次数: 0

Abstract Image

查看原文本刊更多论文

与其他 GLP-1 受体激动剂相比，评估印度 2 型糖尿病患者口服塞马鲁肽的降糖和减轻体重潜力

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Diabetes in Developing Countries ENDOCRINOLOGY & METABOLISM-

CiteScore

1.60

自引率

0.00%

发文量

109

审稿时长

6 months

期刊介绍： International Journal of Diabetes in Developing Countries is the official journal of Research Society for the Study of Diabetes in India. This is a peer reviewed journal and targets a readership consisting of clinicians, research workers, paramedical personnel, nutritionists and health care personnel working in the field of diabetes. Original research articles focusing on clinical and patient care issues including newer therapies and technologies as well as basic science issues in this field are considered for publication in the journal. Systematic reviews of interest to the above group of readers are also accepted.